Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25
11-pentaen-3-yl}ethyl)-N-{2-[2-(2-{[2-(2
MDA-MB-231 breast
tinea cruris
with Ki values of 0
Saxagliptin hydrate esceinamine Isomer II Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25Saxagliptin, also known as BMS 477118, is a new oral hypoglycemic (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose
US$ 319.50
US$ 448.50
US$ 239.50
US$ 211.00
US$ 393.25
US$ 419.50
US$ 455.00
US$ 516.50
US$ 419.50
US$ 230.50
US$ 371.50